menu ☰
menu ˟

Dosage escalation of SCIT safe, tolerable

26 Feb 2016
Patients who received an escalated dosage of subcutaneous immunotherapy across a decreased number of weekly injections tolerated the escalation well with a good safety profile, according to results from an open label phase 2 trial.“The dose escalat...

Click here to view the full article which appeared in Allergy Immunology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.